DocGo Inc. (NASDAQ:DCGO - Free Report) - Research analysts at Northland Capmk cut their FY2024 earnings per share estimates for DocGo in a research report issued to clients and investors on Tuesday, April 9th. Northland Capmk analyst M. Latimore now expects that the company will earn $0.27 per share for the year, down from their prior forecast of $0.29. The consensus estimate for DocGo's current full-year earnings is $0.36 per share.
DocGo (NASDAQ:DCGO - Get Free Report) last issued its earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by ($0.07). DocGo had a return on equity of 2.01% and a net margin of 1.10%. The firm had revenue of $199.25 million for the quarter, compared to analyst estimates of $195.48 million.
DCGO has been the subject of several other research reports. Cantor Fitzgerald decreased their price target on DocGo from $13.00 to $11.00 and set an "overweight" rating for the company in a report on Thursday, February 29th. Canaccord Genuity Group decreased their price target on DocGo from $10.00 to $9.00 and set a "buy" rating for the company in a report on Thursday. Stifel Nicolaus decreased their price target on DocGo from $11.00 to $8.00 and set a "buy" rating for the company in a report on Wednesday. BTIG Research decreased their price target on DocGo from $13.00 to $11.00 and set a "buy" rating for the company in a report on Wednesday. Finally, Needham & Company LLC decreased their price target on DocGo from $14.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, February 29th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $10.83.
Get Our Latest Stock Report on DocGo
DocGo Stock Performance
Shares of NASDAQ:DCGO remained flat at $3.36 during trading on Thursday. The stock had a trading volume of 692,775 shares, compared to its average volume of 1,608,144. DocGo has a one year low of $2.78 and a one year high of $10.82. The stock has a fifty day moving average price of $3.74 and a two-hundred day moving average price of $4.71. The stock has a market capitalization of $349.49 million, a price-to-earnings ratio of 47.93, a price-to-earnings-growth ratio of 0.37 and a beta of 0.91.
Insider Buying and Selling at DocGo
In other DocGo news, Director Michael J. Burdiek acquired 10,000 shares of DocGo stock in a transaction on Thursday, March 14th. The stock was purchased at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the purchase, the director now directly owns 571,595 shares of the company's stock, valued at $2,063,457.95. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 13.78% of the company's stock.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in DCGO. BlackRock Inc. lifted its position in shares of DocGo by 17.7% during the 1st quarter. BlackRock Inc. now owns 1,156,560 shares of the company's stock valued at $10,699,000 after buying an additional 174,087 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of DocGo by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 1,049,027 shares of the company's stock valued at $9,704,000 after buying an additional 14,704 shares during the last quarter. Ergoteles LLC purchased a new position in shares of DocGo during the 1st quarter valued at $333,000. Lazard Asset Management LLC lifted its holdings in DocGo by 99.3% during the 1st quarter. Lazard Asset Management LLC now owns 10,799 shares of the company's stock worth $99,000 after purchasing an additional 5,381 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in DocGo by 2.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 380,127 shares of the company's stock worth $3,517,000 after purchasing an additional 9,397 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company's stock.
DocGo Company Profile
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
